Reaction Details |
| Report a problem with these data |
Target | Nucleotide-binding oligomerization domain-containing protein 2 |
---|
Ligand | BDBM44128 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | uHTS luminescence assay for the identification of compounds that inhibit NOD2 in MDP treated cells |
---|
IC50 | 1950±n/a nM |
---|
Citation | PubChem, PC uHTS luminescence assay for the identification of compounds that inhibit NOD2 in MDP treated cells PubChem Bioassay(2010)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Nucleotide-binding oligomerization domain-containing protein 2 |
---|
Name: | Nucleotide-binding oligomerization domain-containing protein 2 |
Synonyms: | CARD15 | Caspase recruitment domain-containing protein 15 | IBD1 | Inflammatory bowel disease protein 1 | NOD2 | NOD2_HUMAN | Nucleotide-binding oligomerization domain-containing protein 2 | nucleotide-binding oligomerization domain containing 2 |
Type: | PROTEIN |
Mol. Mass.: | 115287.18 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_1454053 |
Residue: | 1040 |
Sequence: | MGEEGGSASHDEEERASVLLGHSPGCEMCSQEAFQAQRSQLVELLVSGSLEGFESVLDWL
LSWEVLSWEDYEGFHLLGQPLSHLARRLLDTVWNKGTWACQKLIAAAQEAQADSQSPKLH
GCWDPHSLHPARDLQSHRPAIVRRLHSHVENMLDLAWERGFVSQYECDEIRLPIFTPSQR
ARRLLDLATVKANGLAAFLLQHVQELPVPLALPLEAATCKKYMAKLRTTVSAQSRFLSTY
DGAETLCLEDIYTENVLEVWADVGMAGPPQKSPATLGLEELFSTPGHLNDDADTVLVVGE
AGSGKSTLLQRLHLLWAAGQDFQEFLFVFPFSCRQLQCMAKPLSVRTLLFEHCCWPDVGQ
EDIFQLLLDHPDRVLLTFDGFDEFKFRFTDRERHCSPTDPTSVQTLLFNLLQGNLLKNAR
KVVTSRPAAVSAFLRKYIRTEFNLKGFSEQGIELYLRKRHHEPGVADRLIRLLQETSALH
GLCHLPVFSWMVSKCHQELLLQEGGSPKTTTDMYLLILQHFLLHATPPDSASQGLGPSLL
RGRLPTLLHLGRLALWGLGMCCYVFSAQQLQAAQVSPDDISLGFLVRAKGVVPGSTAPLE
FLHITFQCFFAAFYLALSADVPPALLRHLFNCGRPGNSPMARLLPTMCIQASEGKDSSVA
ALLQKAEPHNLQITAAFLAGLLSREHWGLLAECQTSEKALLRRQACARWCLARSLRKHFH
SIPPAAPGEAKSVHAMPGFIWLIRSLYEMQEERLARKAARGLNVGHLKLTFCSVGPTECA
ALAFVLQHLRRPVALQLDYNSVGDIGVEQLLPCLGVCKALYLRDNNISDRGICKLIECAL
HCEQLQKLALFNNKLTDGCAHSMAKLLACRQNFLALRLGNNYITAAGAQVLAEGLRGNTS
LQFLGFWGNRVGDEGAQALAEALGDHQSLRWLSLVGNNIGSVGAQALALMLAKNVMLEEL
CLEENHLQDEGVCSLAEGLKKNSSLKILKLSNNCITYLGAEALLQALERNDTILEVWLRG
NTFSLEEVDKLGCRDTRLLL
|
|
|
BDBM44128 |
---|
n/a |
---|
Name | BDBM44128 |
Synonyms: | 1-{4-[(3-chlorophenyl)sulfonyl]-3-nitrobenzoyl}-4-pyridin-2-ylpiperazine | MLS000689253 | SMR000311051 | [4-(3-chlorophenyl)sulfonyl-3-nitro-phenyl]-(4-pyridin-2-ylpiperazin-1-yl)methanone | [4-(3-chlorophenyl)sulfonyl-3-nitro-phenyl]-[4-(2-pyridyl)piperazino]methanone | [4-(3-chlorophenyl)sulfonyl-3-nitrophenyl]-(4-pyridin-2-ylpiperazin-1-yl)methanone | [4-(3-chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone | cid_6002117 |
Type | Small organic molecule |
Emp. Form. | C22H19ClN4O5S |
Mol. Mass. | 486.928 |
SMILES | [O-][N+](=O)c1cc(ccc1S(=O)(=O)c1cccc(Cl)c1)C(=O)N1CCN(CC1)c1ccccn1 |
Structure |
|